Literature DB >> 17621368

Ecstasy (MDMA) and memory function: a meta-analytic update.

Keith R Laws1, Joy Kokkalis.   

Abstract

A meta-analysis was conducted to examine the impact of recreational ecstasy use on short-term memory (STM), long-term memory (LTM), verbal and visual memory. We located 26 studies containing memory data for ecstasy and non-ecstasy users from which effect sizes could be derived. The analyses provided measures of STM and LTM in 610 and 439 ecstasy users and revealed moderate-to-large effect sizes (Cohen's d) of d = -0.63 and d = -0.87, respectively. The difference between STM versus LTM was non-significant. The effect size for verbal memory was large (d = -1.00) and significantly larger than the small effect size for visual memory (d = -0.27). Indeed, our analyses indicate that visual memory may be affected more by concurrent cannabis use. Finally, we found that the total lifetime number of ecstasy tablets consumed did not significantly predict memory performance. Copyright 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17621368     DOI: 10.1002/hup.857

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  21 in total

1.  Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.

Authors:  Christina R Di Iorio; Tristan J Watkins; Mary S Dietrich; Aize Cao; Jennifer U Blackford; Baxter Rogers; Mohammed S Ansari; Ronald M Baldwin; Rui Li; Robert M Kessler; Ronald M Salomon; Margaret Benningfield; Ronald L Cowan
Journal:  Arch Gen Psychiatry       Date:  2011-12-05

2.  Prospective memory deficits in Ecstasy users: effects of longer ongoing task delay interval.

Authors:  Michael Weinborn; Steven Paul Woods; Claire Nulsen; Katherine Park
Journal:  J Clin Exp Neuropsychol       Date:  2011-11-03       Impact factor: 2.475

Review 3.  The preclinical pharmacology of mephedrone; not just MDMA by another name.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 4.  Differential effects of ecstasy on short-term and working memory: a meta-analysis.

Authors:  Claire E Nulsen; Allison M Fox; Geoffrey R Hammond
Journal:  Neuropsychol Rev       Date:  2010-02-16       Impact factor: 7.444

5.  Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.

Authors:  John H Halpern; Andrea R Sherwood; James I Hudson; Staci Gruber; David Kozin; Harrison G Pope
Journal:  Addiction       Date:  2011-02-15       Impact factor: 6.526

Review 6.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

7.  Neuroimaging in human MDMA (Ecstasy) users.

Authors:  Ronald L Cowan; Deanne M Roberts; James M Joers
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

8.  Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.

Authors:  Tristan J Watkins; Vidya Raj; Junghee Lee; Mary S Dietrich; Aize Cao; Jennifer U Blackford; Ronald M Salomon; Sohee Park; Margaret M Benningfield; Christina R Di Iorio; Ronald L Cowan
Journal:  Psychopharmacology (Berl)       Date:  2012-12-16       Impact factor: 4.530

9.  Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users.

Authors:  Thelma Schilt; Maarten W J Koeter; Johan P Smal; Mathilde N Gouwetor; Wim van den Brink; Ben Schmand
Journal:  Psychopharmacology (Berl)       Date:  2009-10-13       Impact factor: 4.530

10.  N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.

Authors:  Ronald L Cowan; James M Joers; Mary S Dietrich
Journal:  Pharmacol Biochem Behav       Date:  2008-11-13       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.